Skip to main content
. 2022 May 28;11(6):727. doi: 10.3390/antibiotics11060727

Table 3.

Summary for the reduction of gingival indices.

Solutions n Weighted Mean Difference (95% Cl) Index Compared Control Follow-up Periods Reference
CHG 3 −1.20 (−0.23 to −2.16) GI or MGI Placebo 6 months [50]
10 −0.21 (−0.11 to −0.31) GI Baseline 4 to 6 weeks [46]
4 −0.185 (−0.285 to −0.086) GI Placebo 6 months [16]
19 −0.223 (−0.412 to −0.034) GI or MGI Baseline ≥ 4 weeks [48]
8 −0.32 (−0.42 to −0.23) GI Baseline 6w, 3m, 6m [49]
EO 9 −1.44 (−0.82 to −2.06) GI or MGI Placebo 6 months [50]
2 −0.133 (−0.194 to −0.072) GI Placebo 6 months [16]
8 −0.537 (−0.764 to −0.311) MGI Placebo 6 months [16]
16 −0.203 (−0.312 to −0.093) GI or MGI Baseline ≥ 4 weeks [48]
2 −0.36 (−0.26 to −0.62) GI 21.6 or 26.9% hydro-alcohol 6 months [52]
11 −0.52 (−0.67 to −0.37) MGI Placebo 6 months [51]
3 −0.24 (−0.46 to −0.01) GI Placebo 6 months [51]
CPC (>0.05%) 2 −1.04 (0.06 to −2.14) * GI or MGI Placebo 6 months [50]
5 −0.70 (−0.83 to −0.57) GI Placebo ≥ 6 weeks [54]
3 −0.344 (−0.627 to −0.062) GI Placebo 6 months [16]
2 −0.357 (−0.483 to −0.231) MGI Placebo 6 months [16]
8 −0.126 (−0.312 to 0.059) *,† GI or MGI Baseline ≥ 4 weeks [48]
CPC (≤0.05%) 3 −0.31 (0.76 to −1.38) * GI or MGI Placebo 6 months [50]
Del 1 −0.06 (1.86 to −1.98) * GI or MGI Placebo 6 months [50]
2 −0.038 (−0.145 to −0.069) * MGI Placebo 6 months [16]
3 −0.014 (−2.337 to 2.308) †,* GI or MGI Baseline ≥ 4 weeks [48]
AmF/SnF
AmF/SnF
1 −0.76 (0.72 to −2.25) * GI or MGI Placebo 6 months [50]
2 −0.248 (−0.427 to −0.069) GI Placebo 6 months [16]
Alexi 1 −0.16 (1.77 to −2.09) * GI or MGI Placebo 6 months [50]
Tric 3 −1.50 (−0.36 to −2.62) GI or MGI Placebo 6 months [50]
Herb 6 −0.15 (−0.32 to 0.01) * GI CHG 4 weeks [57]
5 −0.09 (−0.25 to 0.08) * GI CHG 12 weeks [57]
3 −0.28 (−0.51 to −0.06) GI Placebo 3 w or 3 m [59]
3 −0.59 (−1.08 to −0.11) MGI Placebo 2 to 4 weeks [59]
5 −0.07 (−0.22 to 0.07) * GI CHG 2 to 4 w [59]
Curcumin 6 −0.13 (−0.35 to 0.09) * GI CHG 21 or 28 days [60]
Green Tea 5 0.43(−0.63 to 1.49) * GI CHG 2 to 4 w [63]
ClO2 4 −0.712 (−0.457 to −0.967) GI Placebo 7 to 21 days [33]

n: number of studies, CHG: chlorhexidine gluconate, EO: essential oils (Listerine antiseptic), CPC: cetylpyridinium chloride. Del: delmopinol, AmF/SnF: amine fluoride/stannous fluoride, Alexi: alexidine, Tric: triclosan, GI: gingival index (Löe and Silness), MGI: modified gingival index. Expressed as the summary relative difference, meaning a percentage change from the baseline. * There was no significant difference (p > 0.05).